Sustained Ketamine Effectiveness for Suicidal Ideation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

128 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-12-01

Study Completion Date

2024-09-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As part of the usual clinical activity of the Emergency and Post-Emergency Psychiatric Department, IV ketamine is used to treat suicidal crises in depressed patients hospitalized as an add-on to the treatment of depression. This infusion can be repeated.

Patients are systematically reassessed twice in the month following the last infusion, to ensure that the suicidal crisis is progressing. Psychometric assessments are part of routine care, to ensure systematic evaluation of psychopathology, intensity of depression and suicidality.

Therefore existing data were re-used from the medical records of patients who had received ketamine infusions to assess the effect of ketamine on suicidal ideation and behaviour.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Ketamine in the Acute Phase of Suicidal Ideation

NCT02299440

Suicidal Ideation

COMPLETED PHASE3

The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression

NCT02037503

Suicidal Ideation Major Depressive Disorder Healthy Participants

UNKNOWN PHASE3

Treatment of Suicidal Ideation With Intravenous Ketamine Infusion

NCT01887990

Depression Suicidal Ideation

COMPLETED NA

Ketamine for Mood Disorders With Suicidal Ideation

NCT04099771

Depressive Disorder, Major Suicidal Ideation

UNKNOWN EARLY_PHASE1

Intramuscular Ketamine for Suicidal Ideation

NCT05105061

Suicidal Ideation

WITHDRAWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression - Major Depressive Disorder Suicide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients treated with IV ketamine in the Psychiatric Emergency and Post-Emergency Department (University Hospital, Montpellier) in context of suicidal crisis
* over 18 y.o

Exclusion Criteria

* Opposition to data use
* Subject deprived of liberty (by judicial or administrative decision)
* Subject protected by law (guardianship or curatorship)
* Subject not affiliated to a social security system

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No